Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children
ILOCO
Influence of a Personalized Lung Volume Optimization Maneuver on Lung Aeration and Cardiac Performance in Mechanically Ventilated Children
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this randomized interventional clinical trial is to learn if a standardized lung volume optimization maneuver (LVOM) is beneficial in
- cardiac performance
- lung function Does it make a difference in:
- length of ventilation
- ventilation/perfusion mismatch of the lung
- need for vasopressor support? Main hypotheses of ECMO study: Does a LVOM in children/infants with severe respiratory failure /ARDS
- improve lung compliance and gas exchange
- facilitate lung protective ventilation according to PALICC-2 guidelines
- improve lung aeration and V/Q-matching assessed with EIT Does it make a difference in
- need for ECMO
- duration of ECMO runs
- hemodynamics stability
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Dec 2025
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2025
CompletedFirst Posted
Study publicly available on registry
September 26, 2025
CompletedStudy Start
First participant enrolled
December 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2027
April 9, 2026
April 1, 2026
1.5 years
September 11, 2025
April 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CHD study: Cardiac Index (L/min/BSA) 2. ECMO study: shortening of ECMO duration (Hours)
CHD study: assessed by using POCUS ECMO study: time course (Hours)
perioperatively/periprocedurally
Secondary Outcomes (6)
lung mechanics
perioperatively/periprocedurally
right ventricular performance
perioperatively/periprocedurally
Ventilation distribution
perioperatively/periprocedurally
Lung perfusion
perioperatively/periprocedurally
dead space
perioperatively/periprocedurally
- +1 more secondary outcomes
Study Arms (2)
control
ACTIVE COMPARATORCHD study: This group receives so called standard of care. This includes relatively low levels of PEEP (5cmH2O in case of planned surgery) and no standardized PEEP titration ECMO study: This group receives so called standard of care. This includes PEEP of 10cmH2O, peak inspiratory pressures of 20cmH2O and no standardized PEEP titration
treatment
EXPERIMENTALCHD study: This group receives an individual lung volume optimization maneuver with PEEP titration. PEEP titration is performed while monitoring lung mechanics to optimize end-expiratory lung volume and find final "best PEEP". ECMO study: This group receives an individual lung volume optimization maneuver with PEEP titration during conventional or CDP titration with high frequency oscillatory ventilation. PEEP/CDP titration is performed while monitoring lung mechanics and EIT indices to optimize end-expiratory lung volume and find final "best PEEP/CDP".
Interventions
CHD study: PEEP titration (incremental/decremental) will be performed to optimize lung volume and find levels of PEEP corresponding to the best lung compliance at the end of surgery. Typically PEEP levels between 10-20cmH2O will be applied based on individual response of patients' lung mechanics. Tidal volume will be kept constant at 6ml/kg in cases and controls. Driving pressures will be limited to 15cmH2O. Balance of CO2 will be guaranteed by adjusting respiratory rate. ECMo study: PEEP/CDP titration (incremental/decremental) will be performed to optimize lung volume and find levels of PEEP/CDP corresponding to the best lung compliance, best match of overdistension and collapse and homogenization of tidal volume distribution (EIT) .
CHD study: Patients will receive pressure controlled ventilation with target tidal volume of 6ml/kg and PEEP of 5cmH2O. Driving pressures are limited to 15cmH2O. No LVOM will be applied. ECMO study: patients will receive standard ECMO ventilation (PEEP 10cmH2O and PiP 20cmH2O) without performing LVOM
Eligibility Criteria
You may qualify if:
- congenital heart disease
- surgery with cardiopulmonary bypass
You may not qualify if:
- single ventricle physiology
- ECMO/VAD
- \<36weeks of gestational age
- chronic lung disease
- Endotracheal tube leak \> 15%
- lack of informed consent from parents.
- patients with respiratory failure on ECMO or at risk for ECMO
- invasive ventilation
- \- severe lung hypoplasia or interstitial lung disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
German Heart Center of the Charité
Berlin, 13353, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Statisticians
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Cardiologist/Intensivist
Study Record Dates
First Submitted
September 11, 2025
First Posted
September 26, 2025
Study Start
December 5, 2025
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
December 20, 2027
Last Updated
April 9, 2026
Record last verified: 2026-04